June 3, 2008 - Seattle Children's Hospital is the first pediatric facility to install a 64-slice GE Discovery VCT PET/CT, combining the system with tailored pediatric imaging protocols to allow Children�s radiologists to best meet the needs of its pediatric patients by more accurately diagnosing conditions and pinpointing treatment areas, while protecting children from excessive diagnostic radiation exposure.

The Discovery VCT PET/CT scanner pairs Positron Emission Tomography (PET) with Computed Tomography (CT) and takes 64 pictures of the tumor site that are combined into a comprehensive 3D image allowing radiologists to determine the presence of disease, pinpoint specific biopsy sites and accurately monitor the effects of treatment.

The Discovery VCT PET/CT is most commonly used in oncology to diagnose lymphoma, neuroblastoma, brain tumors, sarcomas and thyroid cancer. Additionally, it can also assist in the diagnosis of myocardial viability, ischemia, coronary artery disease and in localizing epilepsy and seizure origin.

Diagnostic imaging with a PET/CT scanner requires a small amount of radiation. Studies have shown that these small amounts of radiation can slightly increase the risk of adverse health effects. At Seattle Children�s Hospital, PET/CT scans are designed to minimize diagnostic radiation while ensuring image quality. The scans are only performed when the benefit far outweighs the risk of adverse effects.

The PET scan is a metabolic imaging technology that detects changes in cell energy to establish whether tumors are active or inactive. The PET scan also determines if tumors have spread locally, or to outlying locations away from the primary tumor. The CT scan is then used to precisely identify the location of these cells within the childn's body.

For more information: www.gehealthcare.com, www.seattlechildrens.org


Related Content

News | Cardiac Imaging

April 23, 2024 — CDL Nuclear Technologies, a pioneer in advanced diagnostic solutions, is proud to announce the launch ...

Time April 23, 2024
arrow
News | FDA

January 23, 2024 — Siemens Healthineers announces the Food and Drug Administration (FDA) clearance of syngo Virtual ...

Time January 23, 2024
arrow
News | Artificial Intelligence

January 23, 2024 — Quibim announced it has added an industry-leading cancer detection capability to its prostate tool ...

Time January 22, 2024
arrow
News | Radiology Business

December 27, 2023 — The American Roentgen Ray Society (ARRS) announced David M. Naeger, MD, as the 2024 ARRS ...

Time December 27, 2023
arrow
News | Radiopharmaceuticals and Tracers

December 6, 2023 — Philochem AG, a wholly owned subsidiary of Philogen S.p.A., and Blue Earth Diagnostics, a Bracco ...

Time December 06, 2023
arrow
News | Radiology Imaging

November 30, 2023 — Through its leading imaging solutions and commitment to innovation, GE HealthCare remains at the ...

Time November 30, 2023
arrow
News | Quality Assurance (QA)

November 25, 2023 — Mirion announced that it will debut the new Instadose VUE personal dosimeter, from its Dosimetry ...

Time November 25, 2023
arrow
News | PET-CT

November 22, 2023 — Siemens Healthineers has announced the U.S. Food and Drug Administration (FDA) clearance of the ...

Time November 22, 2023
arrow
News | Breast Imaging

October 11, 2023 — A new imaging agent, 68Ga-ABY-025, can predict early metabolic response to human epidermal growth ...

Time October 11, 2023
arrow
News | X-Ray

September 21, 2023 — Scientists in Moscow have successfully engineered a prototype detector for X-ray and PET/CT ...

Time September 21, 2023
arrow
Subscribe Now